Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Edwards, C.M.B.
Right arrow Articles by Chowdhury, T.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edwards, C.M.B.
Right arrow Articles by Chowdhury, T.A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2003; 96: 315-316
© 2003 Association of Physicians

Correspondence

Metformin-associated lactic acidosis in a patient with liver disease

C.M.B. Edwards, M.A. Barton, J. Snook, M. David, V.H.F. Mak and T.A. Chowdhury

Department of Diabetes and Endocrinology Department of Gerontology Department of Intensive Care, Central Middlesex Hospital, London Department of Diabetes and Metabolism, The Royal London Hospital, London e-mail: Tahseen.Chowdhury@bartsandthelondon.nhs.uk

The first 10% of the full text of this article appears below.

Sir,

Metformin is an orally active biguanide, and was found to reduce mortality and complications in obese diabetic patients in the UK Prospective Diabetes Study.1 As a result, the drug is widely used as first-line therapy for patients with obesity and type 2 diabetes. We would like to remind prescribers of a rare, but commonly fatal complication of . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?